Published in Respir Med on September 01, 1991
Clinical Trial of Chinese Herbal Medicine for Idiopathic Pulmonary Fibrosis (IPF) | NCT03274544
Azithromycin for prevention of exacerbations of COPD. N Engl J Med (2011) 8.66
Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial. BMJ (2008) 5.75
GOLD 2011 disease severity classification in COPDGene: a prospective cohort study. Lancet Respir Med (2012) 3.98
The minimal important difference of exercise tests in severe COPD. Eur Respir J (2010) 3.27
Health status measurement in chronic obstructive pulmonary disease. Thorax (2001) 3.07
Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease. Thorax (1997) 2.91
C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax (2005) 2.72
A placebo-controlled, randomized trial of mesenchymal stem cells in COPD. Chest (2013) 2.71
Health-related quality of life is related to COPD disease severity. Health Qual Life Outcomes (2005) 2.42
The SF-36 and SGRQ: validity and first look at minimum important differences in IPF. Respir Med (2009) 2.18
An empirical comparison of the St George's Respiratory Questionnaire (SGRQ) and the Chronic Respiratory Disease Questionnaire (CRQ) in a clinical trial setting. Thorax (1999) 2.15
Relationship between quantitative CT metrics and health status and BODE in chronic obstructive pulmonary disease. Thorax (2012) 2.15
Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax (2002) 2.09
Health status measurement in COPD: the minimal clinically important difference of the clinical COPD questionnaire. Respir Res (2006) 2.03
Comparison of health-related quality of life measures in chronic obstructive pulmonary disease. Health Qual Life Outcomes (2011) 1.94
Impaired sleep reduces quality of life in chronic obstructive pulmonary disease. Lung (2009) 1.88
Measuring health-related quality of life in tuberculosis: a systematic review. Health Qual Life Outcomes (2009) 1.85
Exacerbation rate, health status and mortality in COPD--a review of potential interventions. Int J Chron Obstruct Pulmon Dis (2009) 1.85
Multimorbidity, control and treatment of noncommunicable diseases among primary healthcare attenders in the Western Cape, South Africa. S Afr Med J (2015) 1.81
Patients' perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives. Health Qual Life Outcomes (2005) 1.69
Racial differences in quality of life in patients with COPD. Chest (2011) 1.64
Creating scenarios of the impact of COPD and their relationship to COPD Assessment Test (CAT™) scores. BMC Pulm Med (2011) 1.54
Pilot study of a cell phone-based exercise persistence intervention post-rehabilitation for COPD. Int J Chron Obstruct Pulmon Dis (2009) 1.53
Assessing health status in COPD. A head-to-head comparison between the COPD assessment test (CAT) and the clinical COPD questionnaire (CCQ). BMC Pulm Med (2012) 1.52
Rapid lung function decline in smokers is a risk factor for COPD and is attenuated by angiotensin-converting enzyme inhibitor use. Chest (2014) 1.48
Long-term follow-up after bronchoscopic lung volume reduction treatment with coils in patients with severe emphysema. Respirology (2014) 1.44
Validation of the clinical COPD Questionnaire (CCQ) in primary care. Health Qual Life Outcomes (2009) 1.43
Age and Small Airway Imaging Abnormalities in Subjects With and Without Airflow Obstruction in SPIROMICS. Am J Respir Crit Care Med (2016) 1.39
Study on risk factors and phenotypes of acute exacerbations of chronic obstructive pulmonary disease in Guangzhou, China-design and baseline characteristics. J Thorac Dis (2015) 1.39
Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study. Lancet Respir Med (2014) 1.37
Lung function efficacy and symptomatic benefit of olodaterol once daily delivered via Respimat® versus placebo and formoterol twice daily in patients with GOLD 2-4 COPD: results from two replicate 48-week studies. Int J Chron Obstruct Pulmon Dis (2014) 1.34
Computed tomographic measures of pulmonary vascular morphology in smokers and their clinical implications. Am J Respir Crit Care Med (2013) 1.33
Primary care COPD patients compared with large pharmaceutically-sponsored COPD studies: an UNLOCK validation study. PLoS One (2014) 1.23
The clinical impact of non-obstructive chronic bronchitis in current and former smokers. Respir Med (2013) 1.23
Overtreatment of COPD with inhaled corticosteroids--implications for safety and costs: cross-sectional observational study. PLoS One (2013) 1.18
Primary ciliary dyskinesia (Siewert's/Kartagener's syndrome): respiratory symptoms and psycho-social impact. BMC Pulm Med (2003) 1.17
Patient weighting of importance of asthma symptoms. Thorax (2001) 1.16
Development and validity testing of an IPF-specific version of the St George's Respiratory Questionnaire. Thorax (2010) 1.14
Clinical and radiographic correlates of hypoxemia and oxygen therapy in the COPDGene study. Respir Med (2011) 1.12
Patient-clinician communication: associations with important health outcomes among veterans with COPD. Chest (2010) 1.11
Natural histories of chronic obstructive pulmonary disease. Proc Am Thorac Soc (2008) 1.11
Randomised controlled trial of home based care of patients with chronic obstructive pulmonary disease. BMJ (2002) 1.10
Quality control in microarray assessment of gene expression in human airway epithelium. BMC Genomics (2009) 1.10
Depression and anxiety predict health-related quality of life in chronic obstructive pulmonary disease: systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis (2014) 1.09
Inflammatory and repair serum biomarker pattern: association to clinical outcomes in COPD. Respir Res (2012) 1.07
Factors affecting the relationship between psychological status and quality of life in COPD patients. Health Qual Life Outcomes (2010) 1.06
The SAFE (SGRQ score, air-flow limitation and exercise tolerance) Index: a new composite score for the stratification of severity in chronic obstructive pulmonary disease. Postgrad Med J (2007) 1.05
A randomized controlled trial of a literacy-sensitive self-management intervention for chronic obstructive pulmonary disease patients. J Gen Intern Med (2011) 1.05
The Asthma Control and Communication Instrument: a clinical tool developed for ethnically diverse populations. J Allergy Clin Immunol (2008) 1.05
Assessment of COPD wellness tools for use in primary care: an IPCRG initiative. Int J Chron Obstruct Pulmon Dis (2012) 1.04
Patterns of healthcare utilization by COPD severity: a pilot study. Lung (2008) 1.04
Disability in valued life activities among individuals with COPD and other respiratory conditions. J Cardiopulm Rehabil Prev (2010) 1.01
Predictors of mortality in patients with stable COPD. J Gen Intern Med (2008) 1.01
Health status in COPD cannot be measured by the St George's Respiratory Questionnaire alone: an evaluation of the underlying concepts of this questionnaire. Respir Res (2010) 0.98
Economic evaluation of a community-based pulmonary rehabilitation program for chronic obstructive pulmonary disease. Lung (2004) 0.96
Withdrawal of inhaled corticosteroids in individuals with COPD--a systematic review and comment on trial methodology. Respir Res (2011) 0.96
Characteristics of stable chronic obstructive pulmonary disease patients in the pulmonology clinics of seven Asian cities. Int J Chron Obstruct Pulmon Dis (2013) 0.95
Association between anemia and quality of life in a population sample of individuals with chronic obstructive pulmonary disease. BMC Pulm Med (2006) 0.95
Outcomes in COPD patients receiving tiotropium or salmeterol plus treatment with inhaled corticosteroids. Int J Chron Obstruct Pulmon Dis (2007) 0.95
Item selection, reliability and validity of the Shortness of Breath with Daily Activities (SOBDA) questionnaire: a new outcome measure for evaluating dyspnea in chronic obstructive pulmonary disease. Health Qual Life Outcomes (2013) 0.95
Proposing a standardized method for evaluating patient report of the intensity of dyspnea during exercise testing in COPD. Int J Chron Obstruct Pulmon Dis (2012) 0.94
Health-related quality of life, utility, and productivity outcomes instruments: ease of completion by subjects with COPD. Health Qual Life Outcomes (2003) 0.94
Association of anxiety and depression with pulmonary-specific symptoms in chronic obstructive pulmonary disease. Int J Psychiatry Med (2013) 0.92
Improving the quality of life in patients with chronic obstructive pulmonary disease: focus on indacaterol. Int J Chron Obstruct Pulmon Dis (2013) 0.92
Does the 2013 GOLD classification improve the ability to predict lung function decline, exacerbations and mortality: a post-hoc analysis of the 4-year UPLIFT trial. BMC Pulm Med (2014) 0.92
Validity, reliability, and responsiveness of a new short Visual Simplified Respiratory Questionnaire (VSRQ) for health-related quality of life assessment in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2009) 0.92
Early chronic obstructive pulmonary disease: definition, assessment, and prevention. Lancet (2015) 0.92
Gender influences Health-Related Quality of Life in IPF. Respir Med (2009) 0.92
Action Plan to enhance self-management and early detection of exacerbations in COPD patients; a multicenter RCT. BMC Pulm Med (2009) 0.91
Dynamic expiratory tracheal collapse in COPD: correlation with clinical and physiologic parameters. Chest (2012) 0.91
Do the benefits gained using a short-term pulmonary rehabilitation program remain in COPD patients after participation? Lung (2007) 0.90
Effectiveness and cost-effectiveness of a minimal psychological intervention to reduce non-severe depression in chronically ill elderly patients: the design of a randomised controlled trial [ISRCTN92331982]. BMC Public Health (2006) 0.90
Feasibility and acceptance of electronic quality of life assessment in general practice: an implementation study. Health Qual Life Outcomes (2009) 0.90
What determines subjective health status in patients with chronic obstructive pulmonary disease: importance of symptoms in subjective health status of COPD patients. Health Qual Life Outcomes (2008) 0.89
St. George's Respiratory Questionnaire has longitudinal construct validity in lymphangioleiomyomatosis. Chest (2013) 0.89
Validation of the Cough Quality-of-Life Questionnaire in patients with idiopathic pulmonary fibrosis. Chest (2013) 0.89
Association between pathogens detected using quantitative polymerase chain reaction with airway inflammation in COPD at stable state and exacerbations. Chest (2015) 0.89
Analysis of longitudinal changes in dyspnea of patients with chronic obstructive pulmonary disease: an observational study. Respir Res (2012) 0.88
A score to predict short-term risk of COPD exacerbations (SCOPEX). Int J Chron Obstruct Pulmon Dis (2015) 0.88
Day-to-day measurement of patient-reported outcomes in exacerbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2013) 0.88
Shortness of Breath with Daily Activities questionnaire: validation and responder thresholds in patients with chronic obstructive pulmonary disease. BMJ Open (2013) 0.88
Effect of exacerbations on health status in subjects with chronic obstructive pulmonary disease. Health Qual Life Outcomes (2009) 0.88
A pilot randomised controlled trial of a Telehealth intervention in patients with chronic obstructive pulmonary disease: challenges of clinician-led data collection. Trials (2014) 0.88
An empirical comparison of the WHOQOL-BREF and the SGRQ among patients with COPD. Qual Life Res (2008) 0.88
The psychometric properties of the St George's Respiratory Questionnaire (SGRQ) in patients with idiopathic pulmonary fibrosis: a literature review. Health Qual Life Outcomes (2014) 0.87
Patient-reported outcome measures for chronic obstructive pulmonary disease : the exclusion of people with low literacy skills and learning disabilities. Patient (2013) 0.87
Plasma homocysteine is elevated in COPD patients and is related to COPD severity. Int J Chron Obstruct Pulmon Dis (2007) 0.87
A novel study design for antibiotic trials in acute exacerbations of COPD: MAESTRAL methodology. Int J Chron Obstruct Pulmon Dis (2011) 0.87
Methylated Genes in Sputum Among Older Smokers With Asthma. Chest (2012) 0.87
Comparison between the disease-specific Airways Questionnaire 20 and the generic 15D instruments in COPD. Health Qual Life Outcomes (2011) 0.87
Methods used in internal industry clinical trials to assess tobacco risk reduction. Cancer Epidemiol Biomarkers Prev (2009) 0.87
The impact of disability on depression among individuals with COPD. Chest (2009) 0.86
Effectiveness of holistic interventions for people with severe chronic obstructive pulmonary disease: systematic review of controlled clinical trials. PLoS One (2012) 0.86
Caregiver-assisted coping skills training for patients with COPD: background, design, and methodological issues for the INSPIRE-II study. Clin Trials (2009) 0.86
Health-related quality of life in emphysema. Proc Am Thorac Soc (2008) 0.86
Physical therapy practice patterns in acute exacerbations of chronic obstructive pulmonary disease. Can Respir J (2009) 0.86
A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis (1992) 15.92
Relationships between general health measured with the sickness impact profile and respiratory symptoms, physiological measures, and mood in patients with chronic airflow limitation. Am Rev Respir Dis (1989) 1.56
Asthma health status measurement in clinical practice: validity of a new short and simple instrument. Respir Med (1998) 1.33
Why quality of life measures should be used in the treatment of patients with respiratory illness. Monaldi Arch Chest Dis (1994) 1.26
Randomised controlled trial of the effectiveness of a respiratory health worker in reducing impairment, disability, and handicap due to chronic airflow limitation. Thorax (1991) 1.20
Influence of demographic and disease related factors on the degree of distress associated with symptoms and restrictions on daily living due to asthma in six countries. Eur Respir J (1991) 1.15
Rehabilitation for people with chronic lung disease. Qual Health Care (1995) 0.75